The forecast for bladder malignant neoplasms mortality among men in the UK indicates a declining trend, with the standardized rates decreasing from 10.9 deaths per hundred thousand men in 2024 to 10.3 in 2028. Comparing year-on-year changes, the mortality rate is predicted to reduce by approximately 0.9% in 2025, 1.9% in 2026, and continue at this declining rate through 2028. The compounded annual growth rate (CAGR) forecasts an average decrease of around 1.19% annually over these five years.
Future trends to watch for include advancements in early detection technologies, improved treatment protocols, and public health interventions targeting risk factors such as smoking reduction. These developments may further influence mortality rates and alter future forecasts.
